Advertisement

Organisation › Details
AstraZeneca (Group)
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
In the United States, AstraZeneca is a $12.44 billion healthcare business with more than 12,000 employees. For nearly three decades, AstraZeneca has offered drug assistance programs side by side with its medicines, and over the past five years, has provided over $3 billion in savings to more than 1 million patients throughout the US and Puerto Rico. *
![]() |
Start | 1999-04-05 merged |
Predecessor | Zeneca (Group) | |
![]() |
Industry | pharmaceutical |
![]() |
Person | Soriot, Pascal (AstraZeneca 201210– CEO before Roche COO Pharma Div before Genentech CEO) |
Person 2 | Dunoyer, Marc (AstraZeneca 201311– CFO joined 201303 as EVP Global Portfolio + Product Strategy before GSK) | |
![]() |
Region | United Kingdom (town unspecified) |
Country | United Kingdom (GB) | |
Street | 15 Stanhope Gate | |
City | W1K 1LN London | |
Tel | +44-20-7304-5000 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | I: 50,001 to 100,0 (2019-12-31) |
Currency | USD | |
Annual sales | 24,384,000,000 (revenue, total, consolidated (2019) 2019-12-31) | |
Profit | 1,227,000,000 (2019-12-31) | |
Cash | 5,369,000,000 (2019-12-31) | |
* Document for �About Section�: | ||
Record changed: 2020-10-08 |
Advertisement

More documents for AstraZeneca (Group)
- [1] AstraZeneca plc. (12/30/20). "Press Release: AstraZeneca’s COVID-19 Vaccine Authorised for Emergency Supply in the UK"....
- [2] AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]"....
- [3] Exscientia Ltd.. (11/10/20). "Press Release: Exscientia Recruits Industry Innovator Garry Pairaudeau as Chief Technology Officer"....
- [4] Fusion Antibodies Ltd.. (11/6/20). "Press Release: Fusion Antibodies Announce New Senior Hire to Support Innovation"....
- [5] Nvidia Corporation. (10/5/20). "Press Release: Nvidia Building UK’s Most Powerful Supercomputer, Dedicated to AI Research in Healthcare". Santa Clara, CA....
- [6] Oxford BioMedica plc. (9/1/20). "Press Release: Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222". Oxford....
- [7] Cellink AB. (8/27/20). "Press Release: Cytena and AstraZeneca Collaborate to Develop Plate Based Microbioreactors for Cell Line Development Workflows"....
- [8] Redx Pharma plc. (8/4/20). "Press Release: Redx Signs Out Licensing Agreement with AstraZeneca". Alderley Park....
- [9] ImaginAb, Inc.. (3/30/20). "Press Release: ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology". Los Angeles, CA....
- [10] Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces R&D Update". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top